0001140361-17-011280.txt : 20170309
0001140361-17-011280.hdr.sgml : 20170309
20170309190738
ACCESSION NUMBER: 0001140361-17-011280
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170307
FILED AS OF DATE: 20170309
DATE AS OF CHANGE: 20170309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASAR VINIT K
CENTRAL INDEX KEY: 0001454324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 17679859
MAIL ADDRESS:
STREET 1: HANGER ORTHOPEDIC GROUP, INC.
STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
doc1.xml
FORM 4
X0306
4
2017-03-07
0
0000722723
HANGER, INC.
HGR
0001454324
ASAR VINIT K
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
1
1
0
0
President and CEO
Common Stock
2017-03-07
4
F
0
2857
13.87
D
231310
D
Common Stock
2017-03-08
4
F
0
5332
13.77
D
225978
D
Common Stock
2017-03-08
4
A
0
60000
0
A
285978
D
Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued.
Represents a grant of time-based restricted stock under the Company's 2016 Omnibus Incentive Plan (the "Plan"), which vests to the extent of 25% annually beginning on March 8, 2018 and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 90,000 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2017.
Includes (i) unvested restricted shares totaling 60,000 shares of stock from an initial grant of 60,000 shares of restricted stock that begins to vest on March 8, 2018; (ii) unvested restricted shares and fully vested shares totaling 55,897 shares of stock from an initial grant of 60,000 shares of restricted stock that begins to vest on March 7, 2017; (iii) unvested restricted shares and fully vested shares totaling 39,533 shares of stock from an initial grant of 42,390 shares of restricted stock made on March 6, 2015; (iv) unvested restricted shares and fully vested shares totaling 15,515 shares of stock from an initial grant of 17,973 shares of restricted stock made on March 7, 2014; (v) unvested restricted shares and fully vested shares totaling 23,974 shares of stock from an initial grant of 29,292 shares of restricted stock and performance shares made on March 11, 2013; [continued in next footnote]
(vi) fully vested shares totaling 14,230 shares of stock from an initial grant of 17,250 shares of restricted stock and performance shares made on August 27, 2012; (vii) fully vested shares totaling 19,638 shares of stock from an initial grant of 27,600 shares of restricted stock and performance shares made on March 7, 2012; (viii) fully vested shares totaling 11,589 shares of stock from an initial grant of 15,923 shares of restricted stock and performance shares made on March 25, 2011; (ix) fully vested shares totaling 16,600 shares of stock from an initial grant of 23,000 shares of restricted stock and performance shares made on March 30, 2010; and (x) fully vested shares totaling 29,002 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Vinit K. Asar
2017-03-09